EHI
Eagle Health Investments Portfolio holdings
AUM
$405M
This Quarter Return
+16.32%
1 Year Return
+14.19%
3 Year Return
+134.25%
5 Year Return
–
10 Year Return
–
AUM
$525M
AUM Growth
+$525M
(+6.6%)
Cap. Flow
-$18.8M
Cap. Flow
% of AUM
-3.58%
Top 10 Holdings %
Top 10 Hldgs %
70.89%
Holding
28
New
5
Increased
5
Reduced
9
Closed
1
Top Buys
| 1 |
Ultragenyx Pharmaceutical
RARE
|
$14M |
| 2 |
Guardant Health
GH
|
$12.6M |
| 3 |
Exact Sciences
EXAS
|
$8.36M |
| 4 |
10x Genomics
TXG
|
$5.07M |
| 5 |
Werewolf Therapeutics
HOWL
|
$4.54M |
Top Sells
| 1 |
Alnylam Pharmaceuticals
ALNY
|
$13.2M |
| 2 |
IQVIA
IQV
|
$13.1M |
| 3 |
Sarepta Therapeutics
SRPT
|
$11.1M |
| 4 |
Danaher
DHR
|
$11M |
| 5 |
Adaptive Biotechnologies
ADPT
|
$5.95M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Lantheus
LNTH
$3.75B
| $2.69M | 0.5% |
43,200
| – | – |
|
27
CRISPR Therapeutics
CRSP
$4.82B
| – | – |
0
| – | – |
|
|
28
Adaptive Biotechnologies
ADPT
$1.96B
| – | – |
-1,214,860
| Closed | -$5.95M |
|